debate: strategies for locally advanced nsclc - bimodality approach
Published 8 years ago • 77 plays • Length 10:26Download video MP4
Download video MP3
Similar videos
-
14:43
debate: strategies for locally advanced nsclc - trimodality approach
-
14:46
debate: optimal approach for stage i nsclc - surgery
-
21:16
locally advanced nsclc: choice and sequencing of systemic agents in combined modality therapy
-
14:38
debate: optimal approach for stage iii nsclc - trimodality therapy
-
19:24
debate: optimal approach for stage i nsclc - sbrt
-
7:33
debate: should you use third-line (salvage) therapy to manage patients with advanced nsclc? - no
-
14:00
locally advanced nsclc - state of systemic therapy
-
11:55
debate: should you use third-line (salvage) therapy to manage patients with advanced nsclc? - yes
-
45:05
criticality: a balance between robustness and adaptability
-
6:05
treatment and management of non-small cell lung cancer (nsclc)
-
29:45
lung cancer (small cell lung carcinoma and non-small cell lung carcinoma) for usmle 2
-
11:05
debate: what is the optimal chemotherapy for stage iii nsclc? - taxane/carboplatin is the standard
-
11:56
debate: adjuvant therapy for resected node negative stage i nsclc? - never
-
7:06
debate: should pet scan be used for optimal follow-up in metastatic nsclc? - yes
-
14:39
debate: adjuvant therapy for resected node negative stage i nsclc? - sometimes
-
7:24
debate: surgery for stage iiia patients with lung cancer? - no
-
10:45
debate: what is the optimal chemotherapy for stage iii nsclc? - cisplatin/etoposide is the standard
-
10:45
debate: adjuvant egfr-directed therapy for patients with early stage nsclc? - no
-
13:28
debate: alk positive nsclc - front line therapy - crizotinib
-
11:38
debate: alk positive nsclc - front line therapy - ceritinib
-
16:22
debate: drug of choice for exon 19 del egfr mutant nsclc - afatinib